Lilia K. Koriazova
Sanofi (Turkey)(TR)
Publications by Year
Research Areas
Immune Cell Function and Interaction, Herpesvirus Infections and Treatments, CAR-T cell therapy research, Poxvirus research and outbreaks, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Translocation of botulinum neurotoxin light chain protease through the heavy chain channel(2002)326 cited
- → Therapeutic potential of a fully human monoclonal antibody against influenza A virus M2 protein(2008)144 cited
- → Vaccinia Virus Extracellular Enveloped Virion Neutralization In Vitro and Protection In Vivo Depend on Complement(2008)134 cited
- → An engineered IL-2 reprogrammed for anti-tumor therapy using a semi-synthetic organism(2021)114 cited
- → Heavily Isotype-Dependent Protective Activities of Human Antibodies against Vaccinia Virus Extracellular Virion Antigen B5(2009)70 cited
- → Combination therapy of vaccinia virus infection with human anti-H3 and anti-B5 monoclonal antibodies in a small animal model(2010)67 cited
- → Unusual Features of Vaccinia Virus Extracellular Virion Form Neutralization Resistance Revealed in Human Antibody Responses to the Smallpox Vaccine(2012)37 cited
- → Protection of Rabbits and Immunodeficient Mice against Lethal Poxvirus Infections by Human Monoclonal Antibodies(2012)35 cited
- → Correction: Generation and Improvement of Effector Function of a Novel Broadly Reactive and Protective Monoclonal Antibody against Pneumococcal Surface Protein A of Streptococcus pneumoniae(2017)15 cited
- → Generation and Improvement of Effector Function of a Novel Broadly Reactive and Protective Monoclonal Antibody against Pneumococcal Surface Protein A of Streptococcus pneumoniae(2016)14 cited